Mika Scheinin

Title: The Innovative Contributions of Mika Scheinin

Introduction

Mika Scheinin is a notable inventor based in Naantali, Finland. He has made significant contributions to the field of biotechnology, particularly in the development of methods and compositions for treating various medical conditions. With a total of 3 patents to his name, Scheinin's work has the potential to impact both human health and scientific research.

Latest Patents

One of Scheinin's latest patents is focused on a DNA molecule encoding a variant α2B-adrenoceptor protein and its uses. This invention encompasses a DNA sequence that includes a nucleotide sequence encoding the variant α-adrenoceptor protein. It also details a method for screening subjects to determine if they carry a variant gene that encodes this protein. Furthermore, the patent describes a method for treating mammals suffering from vascular contraction of coronary arteries by administering a selective α-adrenoceptor antagonist. Another significant patent involves a method for treating mental illness in mammals, particularly those affected by stress. This method includes diminishing the tone of endogenous alpha-2C-adrenoceptors in the central nervous system and outlines pharmaceutical compositions useful for this treatment.

Career Highlights

Throughout his career, Mika Scheinin has worked with various companies, including Orion-Yhtyma Oy. His innovative approaches and research have contributed to advancements in medical treatments and biotechnology.

Collaborations

Mika has collaborated with notable individuals in his field, including Mervyn Maze and Antti Haapalinna. These partnerships have likely enhanced the scope and impact of his research.

Conclusion

Mika Scheinin's contributions to biotechnology and medicine through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for new treatments and advancements in health science.